The trajectory of companies tied to iconic drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the expiry in key markets has introduced considerable risk . Investors are now facing the impact of generic competition , shrinking income